INNOVO from Atlantic Therapeutics

INNOVO® is an FDA-Approved, CE-marked treatment for women suffering from Stress Urinary Incontinence. It works by delivering clinically proven, safe, non-invasive pelvic-floor stimulation via unique wearable technology. In the privacy of your own home, you can simply wear the INNOVO® shorts technology for a 30-minute pelvic floor workout. Innovative muscle stimulation technology embedded in the INNOVO shorts does the work to strengthen and re-educate your pelvic floor muscles, giving you the opportunity to live life free from bladder leaks in as little as three months.

About INNOVO

Extensive clinical trial outcomes conducted on with more than 600 research participants consistently confirm that INNOVO is safe, effective, and improves quality of life. Underpinned by this compelling peer-reviewed science, INNOVO® has received numerous prestigious awards for innovation and technology. Over 100,000 people have benefitted from using INNOVO to address their pelvic floor weakness and return them to continence and control.

Visit www.myinnovo.com for more information about INNOVO.

About Atlantic Therapeutics

Based in Galway, Ireland and Boston, MA, Atlantic Therapeutics develops consumer medical devices, related software, apps and connected health technologies to treat all types of incontinence. The company’s mission is to improve the quality of life of millions of people each year, by enabling them to restore and strengthen their pelvic health, thus regaining the confidence and control to lead active lives. Atlantic Therapeutics has attracted both international VC investment and enterprise grant funding and is experiencing high growth, establishing INNOVO® as the leading Femtech solution to treat SUI.